权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

CSHL 2019 Microbiome Conference

CSHL 2019微生物组会议

基本信息

批准号：
9760259
负责人：
DAVID J. STEWART
金额：
$ 1.25万
依托单位：
COLD SPRING HARBOR LABORATORY
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-07-01 至 2020-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9760259
关键词：
Address Affect American Antibiotic Resistance Antimicrobial Resistance Archaea Area Asians Bacteria Bioinformatics Clinical Clinical Research Collaborations Communicable Diseases Communities Computers Data Development Diagnostic Discipline Disease Educational process of instructing Ensure Environment Etiology European Faculty Fostering Functional disorder Genomics Goals Health Health Promotion Human Human Microbiome Immune System Diseases Immune response Immunology Individual Industrialization Infection Inflammatory International Laboratories Length of Stay Longevity Malignant Neoplasms Methods Microbe Microbiology Modeling Oral Participant Pharmaceutical Preparations Play Postdoctoral Fellow Process Proteomics Published Comment Research Research Institute Research Personnel Role Schedule Science Scientist Seasons Selection Criteria Senior Scientist Series Technology Time Underrepresented Minority Viral Virus Woman Work beneficial microorganism career college colonization resistance fungus graduate student gut-brain axis health care delivery host-microbe interactions innovation interest lectures meetings member metabolomics microbial microbial community microbiome microbiome research microorganism interaction next generation novel posters prevent response skills success symposium synthetic biology tool unpublished works

项目摘要

Microbiome July 18 – 21, 2019 The inaugural international Microbiome conference at Cold Spring Harbor Laboratory will focus on latest research to understand the etiology and treatment of a wide-range of microbe-associated diseases, integrating the disciplines of clinical research, microbiology, immunology, bioinformatics and genomics. The coalescence of a wide variety of clinical disorders should promote new interdisciplinary interactions seldom achieved at other microbiome meetings. As well as bringing established leaders as speakers, this meeting will focus on young investigators and trainees to facilitate the scientific interactions necessary to grow this field and develop novel clinical and experimental approaches, diagnostics and therapies. The meeting will provide an in depth focus on both experimental and computational approaches that are being used to elucidate the mechanisms of inflammatory, immunologic and infectious diseases. We will also explore novel roles for the microbiome in drug response and action at a distance (e.g. gut-brain axis). Microbiome studies that are featured in the oral presentations will include bacterial, fungal and viral associated disease, including inter-domain interactions. Oral and poster sessions will focus on major themes of microbiome and the host response, including: microbial succession and stabilization, microbial interactions/colonization resistance, host-microbial interactions, antimicrobial resistance. The oral sessions will begin with 2-3 invited talks from established leaders in the field, followed by 4-6 shorter talks chosen from submitted abstracts. Broad themes for individual sessions include: 1) microbial community assembly from the domain to the strain level; 2) cutting-edge methods to explore microbial functions including metabolomics and proteomic studies; 3) host-microbial interactions in the context of health and diseases such as inflammatory disorders, infections exacerbated by antibiotic resistance and cancer microbiome; 4) synthetic biology and upcoming technologies to modify microbial communities. The inclusion of a poster sessions as well as the allotment of ample time for questions following each talk will encourage extensive discussion between the participants. The meeting will be small enough (200 - 300 scientists) to facilitate these interactions, yet large enough to allow for oral presentations from younger investigators and those with novel perspectives. The integration of a wide variety of aspects of microbiome research will nucleate new interdisciplinary interactions that will drive this innovative translational field. This meeting will be distinct in the opportunities for young investigators to present their work and the coalescence of computational, experimental and clinical disciplines.

微生物组